“…Each type of the hypersensitivity mechanism, with its own characteristics and including specific parts, such as particular cell types, individual immunoglobulin classes, specific mediators, chemotactic factors, cytokines, chemokines, CD molecules, adhesion molecules, enzymes, activated cellular and tissue receptors, may lead to a specific clinical manifestation of the lower asthmatic airways [1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43]. …”